Reducing HIV-Related Inflammation: Safety Study of Ruxolitinib

Reducing HIV-Related Inflammation: Safety Study of Ruxolitinib

Dr Vincent Marconi talks about his study “Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults” which is currently looking for volunteers. For more information about the study or how to join it, call us at 206-744-8883 or email us at actu@uw.edu https://clinicaltrials.gov/ct2/show/N…
Dr Vincent Marconi received his MD at the Johns Hopkins School of Medicine in 2000. He then received training in Internal Medicine and Infectious Diseases at the Brigham and Women’s Hospital and the Massachusetts General Hospital of Harvard Medical School. Currently, he is Professor of Medicine for the Division of Infectious Diseases and Professor of Global Health at the Rollins School of Public Health. In 2014, he became the Director of Infectious Diseases Research at the Atlanta Veterans Affairs Medical Center. Dr Marconi sees patients at both the Infectious Disease Program Ponce Clinic (part of the Grady Health System) as well as the Infectious Disease Clinic of the Atlanta VA Medical Center. He has co-authored over 90 scientific articles.
FOR BACKGROUND INFORMATION ON JAK INHIBITORS IN HIV:
http://www.thebodypro.com/content/702…

To read the transcript of this interview, click here

Share this post